Literature DB >> 23036432

The inflammatory response in sepsis.

Markus Bosmann1, Peter A Ward.   

Abstract

The pathophysiology of sepsis and its accompanying systemic inflammatory response syndrome (SIRS) and the events that lead to multiorgan failure and death are poorly understood. It is known that, in septic humans and rodents, the development of SIRS is associated with a loss of the redox balance, but SIRS can also develop in noninfectious states. In addition, a hyperinflammatory state develops, together with impaired innate immune functions of phagocytes, immunosuppression, and complement activation, collectively leading to septic shock and lethality. Here, we discuss recent insights into the signaling pathways in immune and phagocytic cells that underlie sepsis and SIRS and consider how these might be targeted for therapeutic interventions to reverse or attenuate pathways that lead to lethality during sepsis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036432      PMCID: PMC3543471          DOI: 10.1016/j.it.2012.09.004

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  66 in total

1.  The cholinergic anti-inflammatory pathway and the gastrointestinal tract.

Authors:  Bruno Bonaz
Journal:  Gastroenterology       Date:  2007-10       Impact factor: 22.682

2.  Where have all the T cells gone?

Authors:  Irini Sereti
Journal:  Blood       Date:  2009-07-23       Impact factor: 22.113

3.  Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state.

Authors:  Mustafa Zakkar; Kim Van der Heiden; Le Anh Luong; Hera Chaudhury; Simon Cuhlmann; Shahir S Hamdulay; Rob Krams; Indika Edirisinghe; Irfan Rahman; Harald Carlsen; Dorian O Haskard; Justin C Mason; Paul C Evans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-03       Impact factor: 8.311

Review 4.  Role of oxidative stress in experimental sepsis and multisystem organ dysfunction.

Authors:  Ettore Crimi; Vincenzo Sica; Arthur S Slutsky; Haibo Zhang; Sharon Williams-Ignarro; Louis J Ignarro; Claudio Napoli
Journal:  Free Radic Res       Date:  2006-07

5.  PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2.

Authors:  Marlene T Mathews; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-31       Impact factor: 8.311

6.  The sepsis seesaw: tilting toward immunosuppression.

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Jonathan E McDunn; Thomas A Ferguson
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

7.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 8.  Hydroxyl radical and its scavengers in health and disease.

Authors:  Boguslaw Lipinski
Journal:  Oxid Med Cell Longev       Date:  2011-07-17       Impact factor: 6.543

Review 9.  Sepsis: from bench to bedside.

Authors:  Eliézer Silva; Rogério Da Hora Passos; Maurício Beller Ferri; Luiz Francisco Poli de Figueiredo
Journal:  Clinics (Sao Paulo)       Date:  2008-02       Impact factor: 2.365

10.  The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products.

Authors:  Giuseppina Barrera; Cristina Toaldo; Stefania Pizzimenti; Angelo Cerbone; Piergiorgio Pettazzoni; Mario Umberto Dianzani; Carlo Ferretti
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more
  156 in total

1.  Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera.

Authors:  Richard B Pouw; Mieke C Brouwer; Marlon de Gast; Anna E van Beek; Lambertus P van den Heuvel; Christoph Q Schmidt; Arie van der Ende; Pilar Sánchez-Corral; Taco W Kuijpers; Diana Wouters
Journal:  Blood Adv       Date:  2019-02-26

2.  Sepsis in the severely immunocompromised patient.

Authors:  Andre C Kalil; Steven M Opal
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

3.  The pituitary gland prevents shock-associated death by controlling multiple inflammatory mediators.

Authors:  Arjun Sharma; Sebastian Steven; Markus Bosmann
Journal:  Biochem Biophys Res Commun       Date:  2018-12-20       Impact factor: 3.575

4.  Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia.

Authors:  Lina Wang; Yapeng Cao; B Gorshkov; Yaqi Zhou; Qiuhua Yang; Jiean Xu; Qian Ma; Xiaoyu Zhang; Jingjing Wang; Xiaoxiao Mao; Xianqiu Zeng; Yunchao Su; A D Verin; Mei Hong; Zhiping Liu; Yuqing Huo
Journal:  Pharmacol Res       Date:  2019-06-02       Impact factor: 7.658

Review 5.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

6.  Severe traumatic hemorrhagic shock induces compromised immune barrier function of the mesenteric lymph node leading to an increase in intestinal bacterial translocation.

Authors:  Jian Zhang; Yun Zhang; Tao Xu; Sheng-Jing Pan; Gang Nie; Xiao-Yan Miao; Jun-Yu Qiu; Wen-Qiao Yu; Shao-Yang Zhang; Ting-Bo Liang
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

7.  Chronic Alterations in Systemic Immune Function after Traumatic Brain Injury.

Authors:  Rodney M Ritzel; Sarah J Doran; James P Barrett; Rebecca J Henry; Elise L Ma; Alan I Faden; David J Loane
Journal:  J Neurotrauma       Date:  2018-05-03       Impact factor: 5.269

8.  Leukotriene B4-mediated sterile inflammation promotes susceptibility to sepsis in a mouse model of type 1 diabetes.

Authors:  Luciano Ribeiro Filgueiras; Stephanie L Brandt; Soujuan Wang; Zhuo Wang; David L Morris; Carmella Evans-Molina; Raghavendra G Mirmira; Sonia Jancar; C Henrique Serezani
Journal:  Sci Signal       Date:  2015-01-27       Impact factor: 8.192

9.  Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis.

Authors:  Georg F Weber; Benjamin G Chousterman; Shun He; Ashley M Fenn; Manfred Nairz; Atsushi Anzai; Thorsten Brenner; Florian Uhle; Yoshiko Iwamoto; Clinton S Robbins; Lorette Noiret; Sarah L Maier; Tina Zönnchen; Nuh N Rahbari; Sebastian Schölch; Anne Klotzsche-von Ameln; Triantafyllos Chavakis; Jürgen Weitz; Stefan Hofer; Markus A Weigand; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

Review 10.  Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.

Authors:  D C Mastellos; D Ricklin; E Hajishengallis; G Hajishengallis; J D Lambris
Journal:  Mol Oral Microbiol       Date:  2015-10-07       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.